Skystar Bio-Pharmaceutical Co (FRA:GNJC) EBITDA Margin % : 34.41% (As of Sep. 2014)

Skystar Bio-Pharmaceutical Co EBITDA Margin % Chart

Skystar Bio-Pharmaceutical Co Annual Data
	Trend	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13
EBITDA Margin %		Get a 7-Day Free Trial					34.71	39.36	35.13	31.50	35.91

Skystar Bio-Pharmaceutical Co Quarterly Data
	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14
EBITDA Margin %	Get a 7-Day Free Trial															32.44	35.58	28.46	29.23	34.41

Competitive Comparison of Skystar Bio-Pharmaceutical Co's EBITDA Margin %

For the Drug Manufacturers - General subindustry, Skystar Bio-Pharmaceutical Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Skystar Bio-Pharmaceutical Co's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Skystar Bio-Pharmaceutical Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Skystar Bio-Pharmaceutical Co's EBITDA Margin % falls into.

Skystar Bio-Pharmaceutical Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Skystar Bio-Pharmaceutical Co's EBITDA Margin % for the fiscal year that ended in Dec. 2013 is calculated as

Skystar Bio-Pharmaceutical Co's EBITDA Margin % for the quarter that ended in Sep. 2014 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Skystar Bio-Pharmaceutical Co  (FRA:GNJC) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Skystar Bio-Pharmaceutical Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Skystar Bio-Pharmaceutical Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Skystar Bio-Pharmaceutical Co (FRA:GNJC) Business Description